- AU$2.44bn
- AU$2.18bn
- AU$7.06m
Brief: 4Dmedical Ltd Says US Bill Directs VA To Adopt 4D Lung Imaging
Australia's 4DMedical rises after US lawmakers introduce VA pilot programme bill
Brief: 4Dmedical Seeks Trading Halt
Brief: 4Dmedical Receives TGA Approval For CTVQ In Australia
Brief: 4Dmedical Launches Clear Clinical Evidence Program
Brief: 4Dmedical Creates EU Platform Via Contextflow Acquisition
Australia's 4DMedical rises on establishing European platform via acquisition
Brief: 4Dmedical Says CT:VQ Enters US Outpatient Market Via Simonmed's 170-Site Network
Brief: 4Dmedical Executes Contract With Glaxosmithkline For Lung Imaging Analytics
Australia's 4DMedical jumps on GSK contract and ASX200 inclusion
Brief: 4DMedical Says CT:VQ Receives CE Mark Certification For Commercial Use In European Union
Australia's 4DMedical hits record high on EU nod, premium placement
Australia's 4D Medical hits record high on tech deployment by Mayo Clinic
Brief: 4DMedical Posts Half-Year Net Loss A$153.9 Million
Australia's Cyclopharm rises on med-tech clinical guideline win in US
Brief: 4Dmedical Secures Us$100+ Million Funding To Accelerate U.S. Expansion And Increase Technology Dominance In Software-Based Lung Imaging
Brief: 4DMedical Completes A$150 MLN Institutional Placement At A$3.80 Per Share
Australia's 4DMedical falls on discounted placement
Brief: 4Dmedical Seeks Trading Halt For Capital Raising Consideration